CARB-X is accelerating global antibacterial innovation by investing in the development of new antibiotics and other life-saving products to combat the most dangerous drug-resistant bacteria. Their projects represent the world’s largest pre-clinical and early development pipeline of antibiotics and other therapeutics, diagnostics, microbiome, vaccines, and devices. We partnered with CARB-X to create a brand that speaks to funders, scientists, and the general public. We updated their logo to be more legible, and to clearly define the organizations’s name. Setting up a plan for a robust website provided space for statistics, education on antibiotic resistance and overuse, resources, meetings, and a clear story about the organization’s value in supporting global health. Custom photos, icons, and infographics support their message and create the basis for a full organizational brand.